Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cellsMethi Wathikthinnakon, Aussara Panya|Scientific Reports|2022Cited by 33